|
DCAF6 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.03190000000364E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.600200E-04 |
| Normal-vs-Stage2 |
4.014400E-02 |
| Normal-vs-Stage3 |
5.319600E-03 |
| Normal-vs-Stage4 |
9.895900E-02 |
| Stage1-vs-Stage2 |
9.301600E-01 |
| Stage1-vs-Stage3 |
1.385150E-01 |
| Stage1-vs-Stage4 |
2.956200E-01 |
| Stage2-vs-Stage3 |
2.156000E-01 |
| Stage2-vs-Stage4 |
4.101200E-01 |
| Stage3-vs-Stage4 |
8.655200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.88870000042918E-07 |
| Normal-vs-AfricanAmerican |
6.060700E-03 |
| Normal-vs-Asian |
5.648600E-01 |
| Caucasian-vs-AfricanAmerican |
1.664230E-01 |
| Caucasian-vs-Asian |
5.479200E-01 |
| AfricanAmerican-vs-Asian |
8.018400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.150940E-04 |
| Normal-vs-Female |
5.13469999963156E-07 |
| Male-vs-Female |
2.999900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.141570E-02 |
| Normal-vs-Extreme_Weight |
1.463960E-03 |
| Normal-vs-Obese |
4.151000E-04 |
| Normal-vs-Extreme_Obese |
4.054400E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.787600E-01 |
| Normal_Weight-vs-Obese |
8.351400E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.242600E-01 |
| Extreme_Weight-vs-Obese |
7.863000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.125800E-01 |
| Obese-vs-Extreme_Obese |
4.690600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.803200E-03 |
| Normal-vs-Age(41-60Yrs) |
2.09890000002488E-06 |
| Normal-vs-Age(61-80Yrs) |
4.199500E-04 |
| Normal-vs-Age(81-100Yrs) |
8.644600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.100400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.297800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.595800E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.542800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.334100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.846200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.49630000001455E-06 |
| Normal-VS-Type2 PRCC |
1.516370E-02 |
| Normal-VS-KIRP CIMP |
3.372100E-02 |
| Normal-VS-Unclassified PRCC |
5.224900E-03 |
| Type1 PRCC-VS-Type2 PRCC |
3.386800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.265800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.392200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.430800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.412000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.847400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.299760E-01 |
| Normal-vs-N1 |
4.815800E-03 |
| Normal-vs-N2 |
1.718060E-03 |
| N0-vs-N1 |
1.784270E-02 |
| N0-vs-N2 |
1.514570E-01 |
| N1-vs-N2 |
6.667400E-01 |
|
|
